Global Exosome Diagnostic and Therapeutic Market Size, Share & Industry Trends Analysis Report By Application (Diagnostic and Therapeutic), By Product (Reagent, Instrument, and Software), By End User, By Regional Outlook and Forecast, 2022

List of Tables

The Global Exosome Diagnostic and Therapeutic Market size is expected to reach $1.4 billion by 2028, rising at a market growth of 26.5% CAGR during the forecast period.

An exosome is a membrane-bound vesicle produced by eukaryotic cells in their extracellular compartment. Immune responses, viral pathogenicity, pregnancy, cardiovascular disorders, central nervous system-related diseases, and cancer progression are all linked to exosomes. Exosomes effectively transfer biomolecules such as metabolites, proteins, and nucleic acids into target cells to affect their biological response. Exosomes are designed to carry a variety of therapeutic payloads, including short interfering ribonucleic acids (RNAs), antisense oligonucleotides, chemotherapeutic drugs, and immunological modulators, to specific targets. Exosome vesicle-based liquid biopsy has the potential to be employed in the diagnosis and prognosis of cancer and other illnesses in patients.

Increased usage of exosome therapy's multifunctional properties for chronic heart failure, Alzheimer's disease, Parkinson's disease, and cancer, including breast, liver, prostate, and lung cancer, is a key factor driving the research on exosomes. Aethlon Medical, a healthcare startup, also announced a collaboration with the University of Pittsburgh on a National Institute of Health grant for the treatment of head and neck cancer in August 2020. Exosomes are nano-sized particles that are released in great quantities by cancer cells that contain a tumor's genetic and protein cargo, fueling cancer growth and suppressing the immune system.

The rising prevalence of cancer, technological breakthroughs in exosome isolation and analysis methods, and expanding sophisticated uses of exosomes are all factors driving market expansion. The increased demand for exosomes is directly related to the rising prevalence of cancer patients. According to the GLOBOCAN 2020 report, 19.29 million new cancer cases were diagnosed in 2020, with this number anticipated to climb over the next two decades. Further, the American Cancer Society predicted that 1,898,160 new instances of cancer would be identified in the United States in 2021, with 608,570 people dying from the disease in 2020.

COVID-19 Impact

The global COVID-19 pandemic wreaked havoc on people's health and the economy. It has influenced entire economies and enterprises, as well as individual careers and personal lives. The stress of maintaining income levels at pre-COVID levels has become the new normal as firms shift their focus away from development prospects and onto implementing exceptional steps to limit the detrimental impact of the COVID-19 pandemic. In the ongoing fight against COVID-19, pharmaceutical and healthcare corporations, governments, and the greater scientific community are all striving to quantify the virus's impact and deliver quick, precise therapies.

Market Growth Factors

Rising Incidence of Cardiovascular Diseases

Exosome diagnostic and therapeutic markets are growing in response to the rising prevalence of cardiovascular diseases (CVDs). This is due to the advancement of technologically advanced devices that have a long lifespan. Unhealthy eating habits, tobacco consumption, and lack of physical activity are only a few of the key causes of cardiovascular disease, which increase blood pressure and blood glucose levels, resulting in overweight and obesity. According to the World Health Organization, heart attacks and strokes account for four out of every five cardiovascular fatalities, with one-third of these deaths occurring in adults under the age of 70.

Role of Exosomes in Modulating Immune Systems

An immune system imbalance could cause the inflammatory pathway to overreact. Inflammation is triggered by tissue injury or pathogen detection. The probability of malignant cell transformation has been linked to chronic inflammation. If cancer progresses, many immune system modulations are necessary, including apoptosis, proliferation, and angiogenesis. The accumulation of inflammatory mediators (Stat3, IL-6, and TNF-alpha) leads to immunosuppression and cancer growth. Exosomes can play a role in the control and modulation of immunological players by blocking or encouraging their activity.

Market Restraining Factors

High Cost of Diagnosis and Limited Use of Exosomes in Diagnosis of CNS Diseases

Affordability concerns related to high diagnostic costs and a high incidence of cancer in low-income groups are two reasons that are expected to slow the expansion of the exosome diagnostic and therapeutic market. Lack of validation standardization for exosome isolation and inadequate insurance coverage of high-cost tests are also expected to stymie market expansion. While exosomes' diagnostic potential has been widely recognized and investigated, such as in brain cancer, the use of exosomes for diagnostics and biomarker discovery in central nervous system (CNS) illnesses is still in its early stages of discovery and development.

Application Outlook

Based on Application, the market is segmented into Diagnostic and Therapeutic. The diagnostic segment acquired the largest revenue share in the exosome diagnostic and therapeutic market in 2021. This is due to a rise in chronic disease incidence and a surge in demand for early detection. Another aspect driving this market's demand is the emergence of an explicit approach to studying exosome-specific proteins. Moreover, the rising demand for additional development and research activities, which is further encouraged by government organization policies around the world, is one of the major factors driving this market's demand upward. Other key factors are the increasing adoption of exosomes based on CTC and CTDNA.

Product Outlook

Based on Product, the market is segmented into Reagent, Instrument, and Software. The instrument segment procured a substantial revenue share in the exosome diagnostic and therapeutic market in 2021. Instruments are essentially used to extract and analyze exosome samples. The largest market share is due to developments in R&D activities in the healthcare industry and an expansion in the number of important manufacturers. For instance, the Thermo Fisher Scientific KingFisher Apex Purification System, a high-throughput sample purification equipment designed for scientists that need to automate the extraction of DNA, RNA, proteins, and cells from a variety of sample types, was released in April 2021.

End User Outlook

Based on End User, the market is segmented into Cancer Institute, Hospital, Diagnostic Center, and Others. The cancer institute segment acquired the largest revenue share in the exosome diagnostic and therapeutic market in 2021. This is attributable to an increase in cancer incidence, an increase in the number of hospitals, and a spike in government measures to expand healthcare infrastructure.

Regional Outlook

Based on Regions, the market is segmented into North America, Europe, Asia Pacific, and Latin America, Middle East & Africa. North America acquired the largest revenue share in the exosome diagnostic and therapeutic market in 2021. This is due to a growth in the incidence of chronic diseases, an increase in the number of exosome therapies product launches, an increase in the presence of important companies, and the expansion of research and development activities in the pharmaceutical and biopharmaceutical sectors in the region. The United States government spends trillions of dollars on improving the healthcare infrastructure and accessibility each year. This has resulted in the growth of the exosome diagnostic and therapeutic market in the country.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Bio-Techne Corporation, Qiagen N.V., Thermo Fisher Scientific, Inc., Aethlon Medical, Inc., Capricor Therapeutics, Inc., Malvern Panalytical Ltd., NanoSomix, Inc., System Biosciences, LLC, and NX Pharmagen, Inc.

Strategies Deployed in Exosome Diagnostic and Therapeutic Market

Feb-2022: Thermo Fisher Scientific signed an agreement with Bio-Techne Corporation, a company that develops, manufactures, and sells life science reagents, instruments, and services. Under the agreement, Bio-Techne aimed to exclusively finish the design of and commercialize the ExoTRU kidney transplant rejection test developed by Exosome Diagnostics, a Bio-Techne brand. ExoTRU is a non-invasive multigene urine-based liquid biopsy test that offers crucial allograft health information to help clinician decision-making in handling kidney transplant patients and optimizing patient care.

Jan-2022: Capricor Therapeutics signed an agreement with Nippon Shinyaku, a company that manufactures health foods and pharmaceutical products. The agreement was an exclusive distribution agreement for CAP-1002 for the treatment of Duchenne muscular dystrophy (DMD) in the US region. CAP-1002 consists of human allogeneic cardiosphere-derived cells. Exosomes (extracellular vesicles) discharged by CAP-1002 are considered to be the mechanism of action of CAP-1002 and have been demonstrated to decrease oxidative stress, inflammation, fibrosis, and expand myocyte generation, as well as enhance motor and cardiac function

Mar-2018: Exosome Diagnostics, subsidiary of Bio-Techne Corporation, teamed up with Intezyne, a clinical-stage biotechnology company focusing on enhancing the effectiveness of cancer treatments. Under the collaboration, both companies developed and validated an extremely sensitive exosomal RNA-based assay for use in Intezyne's Phase 1/2 clinical trials of IT-139, a novel Cancer Resistance Pathway (CRP) inhibitor for the treatment of pancreatic, gastric, and other cancers along with pre-existing anti-cancer therapies. The assay utilizes Exosome Diagnostics' ExoLution isolation kit, a cGMP-grade exosome RNA isolation platform, and is deliberated for the stratification and long-term tracking of patients

Mar-2018: Thermo Fisher Scientific entered into an agreement with Biocept, a company supplying liquid biopsy tests developed to deliver physicians with clinically actionable information to enhance the outcomes of patients diagnosed with cancer. As per the agreement, both companies committed to working together commercially. The agreement also included a plan to analyze the possibility of designing best-in-class products based on the merger of Biocept's Target Selector technology with Thermo Fisher's Ion Torrent NGS platform and Oncomine liquid biopsy-based NGS panels.

Scope of the Study

Market Segments covered in the Report:

By Application

Diagnostic
Therapeutic

By Product

Reagent
Instrument
Software

By End User

Cancer Institute
Hospital
Diagnostic Center
Others

By Geography

North America
- US
- Canada
- Mexico
- Rest of North America
Europe
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
LAMEA
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA

Companies Profiled

Bio-Techne Corporation
Qiagen N.V.
Thermo Fisher Scientific, Inc.
Aethlon Medical, Inc.
Capricor Therapeutics, Inc.
Malvern Panalytical Ltd.
NanoSomix, Inc.
System Biosciences, LLC
NX Pharmagen, Inc.

Unique Offerings from KBV Research

Exhaustive coverage
Highest number of market tables and figures
Subscription based model available
Guaranteed best price
Assured post sales research support with 10% customization free

Chapter 1. Market Scope & Methodology

1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
- 1.4.1 Global Exosome Diagnostic and Therapeutic Market, by Application
- 1.4.2 Global Exosome Diagnostic and Therapeutic Market, by Product
- 1.4.3 Global Exosome Diagnostic and Therapeutic Market, by End User
- 1.4.4 Global Exosome Diagnostic and Therapeutic Market, by Geography
1.5 Methodology for the research

Chapter 2. Market Overview

2.1 Introduction
- 2.1.1 Overview
  - 2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
- 2.2.1 Market Drivers
- 2.2.2 Market Restraints

Chapter 3. Strategies Deployed in Exosome Diagnostic and Therapeutic Market

Chapter 4. Global Exosome Diagnostic and Therapeutic Market by Application

4.1 Global Diagnostic Market by Region
4.2 Global Therapeutic Market by Region

Chapter 5. Global Exosome Diagnostic and Therapeutic Market by Product

5.1 Global Reagent Market by Region
5.2 Global Instrument Market by Region
5.3 Global Software Market by Region

Chapter 6. Global Exosome Diagnostic and Therapeutic Market by End User

6.1 Global Cancer Institute Market by Region
6.2 Global Hospital Market by Region
6.3 Global Diagnostic Center Market by Region
6.4 Global Others Market by Region

Chapter 7. Global Exosome Diagnostic and Therapeutic Market by Region

7.1 North America Exosome Diagnostic and Therapeutic Market
- 7.1.1 North America Exosome Diagnostic and Therapeutic Market by Application
  - 7.1.1.1 North America Diagnostic Market by Country
  - 7.1.1.2 North America Therapeutic Market by Country
- 7.1.2 North America Exosome Diagnostic and Therapeutic Market by Product
  - 7.1.2.1 North America Reagent Market by Country
  - 7.1.2.2 North America Instrument Market by Country
  - 7.1.2.3 North America Software Market by Country
- 7.1.3 North America Exosome Diagnostic and Therapeutic Market by End User
  - 7.1.3.1 North America Cancer Institute Market by Country
  - 7.1.3.2 North America Hospital Market by Country
  - 7.1.3.3 North America Diagnostic Center Market by Country
  - 7.1.3.4 North America Others Market by Country
- 7.1.4 North America Exosome Diagnostic and Therapeutic Market by Country
  - 7.1.4.1 US Exosome Diagnostic and Therapeutic Market
    - 7.1.4.1.1 US Exosome Diagnostic and Therapeutic Market by Application
    - 7.1.4.1.2 US Exosome Diagnostic and Therapeutic Market by Product
    - 7.1.4.1.3 US Exosome Diagnostic and Therapeutic Market by End User
  - 7.1.4.2 Canada Exosome Diagnostic and Therapeutic Market
    - 7.1.4.2.1 Canada Exosome Diagnostic and Therapeutic Market by Application
    - 7.1.4.2.2 Canada Exosome Diagnostic and Therapeutic Market by Product
    - 7.1.4.2.3 Canada Exosome Diagnostic and Therapeutic Market by End User
  - 7.1.4.3 Mexico Exosome Diagnostic and Therapeutic Market
    - 7.1.4.3.1 Mexico Exosome Diagnostic and Therapeutic Market by Application
    - 7.1.4.3.2 Mexico Exosome Diagnostic and Therapeutic Market by Product
    - 7.1.4.3.3 Mexico Exosome Diagnostic and Therapeutic Market by End User
  - 7.1.4.4 Rest of North America Exosome Diagnostic and Therapeutic Market
    - 7.1.4.4.1 Rest of North America Exosome Diagnostic and Therapeutic Market by Application
    - 7.1.4.4.2 Rest of North America Exosome Diagnostic and Therapeutic Market by Product
    - 7.1.4.4.3 Rest of North America Exosome Diagnostic and Therapeutic Market by End User
7.2 Europe Exosome Diagnostic and Therapeutic Market
- 7.2.1 Europe Exosome Diagnostic and Therapeutic Market by Application
  - 7.2.1.1 Europe Diagnostic Market by Country
  - 7.2.1.2 Europe Therapeutic Market by Country
- 7.2.2 Europe Exosome Diagnostic and Therapeutic Market by Product
  - 7.2.2.1 Europe Reagent Market by Country
  - 7.2.2.2 Europe Instrument Market by Country
  - 7.2.2.3 Europe Software Market by Country
- 7.2.3 Europe Exosome Diagnostic and Therapeutic Market by End User
  - 7.2.3.1 Europe Cancer Institute Market by Country
  - 7.2.3.2 Europe Hospital Market by Country
  - 7.2.3.3 Europe Diagnostic Center Market by Country
  - 7.2.3.4 Europe Others Market by Country
- 7.2.4 Europe Exosome Diagnostic and Therapeutic Market by Country
  - 7.2.4.1 Germany Exosome Diagnostic and Therapeutic Market
    - 7.2.4.1.1 Germany Exosome Diagnostic and Therapeutic Market by Application
    - 7.2.4.1.2 Germany Exosome Diagnostic and Therapeutic Market by Product
    - 7.2.4.1.3 Germany Exosome Diagnostic and Therapeutic Market by End User
  - 7.2.4.2 UK Exosome Diagnostic and Therapeutic Market`
    - 7.2.4.2.1 UK Exosome Diagnostic and Therapeutic Market by Application
    - 7.2.4.2.2 UK Exosome Diagnostic and Therapeutic Market by Product
    - 7.2.4.2.3 UK Exosome Diagnostic and Therapeutic Market by End User
  - 7.2.4.3 France Exosome Diagnostic and Therapeutic Market
    - 7.2.4.3.1 France Exosome Diagnostic and Therapeutic Market by Application
    - 7.2.4.3.2 France Exosome Diagnostic and Therapeutic Market by Product
    - 7.2.4.3.3 France Exosome Diagnostic and Therapeutic Market by End User
  - 7.2.4.4 Russia Exosome Diagnostic and Therapeutic Market
    - 7.2.4.4.1 Russia Exosome Diagnostic and Therapeutic Market by Application
    - 7.2.4.4.2 Russia Exosome Diagnostic and Therapeutic Market by Product
    - 7.2.4.4.3 Russia Exosome Diagnostic and Therapeutic Market by End User
  - 7.2.4.5 Spain Exosome Diagnostic and Therapeutic Market
    - 7.2.4.5.1 Spain Exosome Diagnostic and Therapeutic Market by Application
    - 7.2.4.5.2 Spain Exosome Diagnostic and Therapeutic Market by Product
    - 7.2.4.5.3 Spain Exosome Diagnostic and Therapeutic Market by End User
  - 7.2.4.6 Italy Exosome Diagnostic and Therapeutic Market
    - 7.2.4.6.1 Italy Exosome Diagnostic and Therapeutic Market by Application
    - 7.2.4.6.2 Italy Exosome Diagnostic and Therapeutic Market by Product
    - 7.2.4.6.3 Italy Exosome Diagnostic and Therapeutic Market by End User
  - 7.2.4.7 Rest of Europe Exosome Diagnostic and Therapeutic Market
    - 7.2.4.7.1 Rest of Europe Exosome Diagnostic and Therapeutic Market by Application
    - 7.2.4.7.2 Rest of Europe Exosome Diagnostic and Therapeutic Market by Product
    - 7.2.4.7.3 Rest of Europe Exosome Diagnostic and Therapeutic Market by End User
7.3 Asia Pacific Exosome Diagnostic and Therapeutic Market
- 7.3.1 Asia Pacific Exosome Diagnostic and Therapeutic Market by Application
  - 7.3.1.1 Asia Pacific Diagnostic Market by Country
  - 7.3.1.2 Asia Pacific Therapeutic Market by Country
- 7.3.2 Asia Pacific Exosome Diagnostic and Therapeutic Market by Product
  - 7.3.2.1 Asia Pacific Reagent Market by Country
  - 7.3.2.2 Asia Pacific Instrument Market by Country
  - 7.3.2.3 Asia Pacific Software Market by Country
- 7.3.3 Asia Pacific Exosome Diagnostic and Therapeutic Market by End User
  - 7.3.3.1 Asia Pacific Cancer Institute Market by Country
  - 7.3.3.2 Asia Pacific Hospital Market by Country
  - 7.3.3.3 Asia Pacific Diagnostic Center Market by Country
  - 7.3.3.4 Asia Pacific Others Market by Country
- 7.3.4 Asia Pacific Exosome Diagnostic and Therapeutic Market by Country
  - 7.3.4.1 China Exosome Diagnostic and Therapeutic Market
    - 7.3.4.1.1 China Exosome Diagnostic and Therapeutic Market by Application
    - 7.3.4.1.2 China Exosome Diagnostic and Therapeutic Market by Product
    - 7.3.4.1.3 China Exosome Diagnostic and Therapeutic Market by End User
  - 7.3.4.2 Japan Exosome Diagnostic and Therapeutic Market
    - 7.3.4.2.1 Japan Exosome Diagnostic and Therapeutic Market by Application
    - 7.3.4.2.2 Japan Exosome Diagnostic and Therapeutic Market by Product
    - 7.3.4.2.3 Japan Exosome Diagnostic and Therapeutic Market by End User
  - 7.3.4.3 India Exosome Diagnostic and Therapeutic Market
    - 7.3.4.3.1 India Exosome Diagnostic and Therapeutic Market by Application
    - 7.3.4.3.2 India Exosome Diagnostic and Therapeutic Market by Product
    - 7.3.4.3.3 India Exosome Diagnostic and Therapeutic Market by End User
  - 7.3.4.4 South Korea Exosome Diagnostic and Therapeutic Market
    - 7.3.4.4.1 South Korea Exosome Diagnostic and Therapeutic Market by Application
    - 7.3.4.4.2 South Korea Exosome Diagnostic and Therapeutic Market by Product
    - 7.3.4.4.3 South Korea Exosome Diagnostic and Therapeutic Market by End User
  - 7.3.4.5 Singapore Exosome Diagnostic and Therapeutic Market
    - 7.3.4.5.1 Singapore Exosome Diagnostic and Therapeutic Market by Application
    - 7.3.4.5.2 Singapore Exosome Diagnostic and Therapeutic Market by Product
    - 7.3.4.5.3 Singapore Exosome Diagnostic and Therapeutic Market by End User
  - 7.3.4.6 Malaysia Exosome Diagnostic and Therapeutic Market
    - 7.3.4.6.1 Malaysia Exosome Diagnostic and Therapeutic Market by Application
    - 7.3.4.6.2 Malaysia Exosome Diagnostic and Therapeutic Market by Product
    - 7.3.4.6.3 Malaysia Exosome Diagnostic and Therapeutic Market by End User
  - 7.3.4.7 Rest of Asia Pacific Exosome Diagnostic and Therapeutic Market
    - 7.3.4.7.1 Rest of Asia Pacific Exosome Diagnostic and Therapeutic Market by Application
    - 7.3.4.7.2 Rest of Asia Pacific Exosome Diagnostic and Therapeutic Market by Product
    - 7.3.4.7.3 Rest of Asia Pacific Exosome Diagnostic and Therapeutic Market by End User
7.4 LAMEA Exosome Diagnostic and Therapeutic Market
- 7.4.1 LAMEA Exosome Diagnostic and Therapeutic Market by Application
  - 7.4.1.1 LAMEA Diagnostic Market by Country
  - 7.4.1.2 LAMEA Therapeutic Market by Country
- 7.4.2 LAMEA Exosome Diagnostic and Therapeutic Market by Product
  - 7.4.2.1 LAMEA Reagent Market by Country
  - 7.4.2.2 LAMEA Instrument Market by Country
  - 7.4.2.3 LAMEA Software Market by Country
- 7.4.3 LAMEA Exosome Diagnostic and Therapeutic Market by End User
  - 7.4.3.1 LAMEA Cancer Institute Market by Country
  - 7.4.3.2 LAMEA Hospital Market by Country
  - 7.4.3.3 LAMEA Diagnostic Center Market by Country
  - 7.4.3.4 LAMEA Others Market by Country
- 7.4.4 LAMEA Exosome Diagnostic and Therapeutic Market by Country
  - 7.4.4.1 Brazil Exosome Diagnostic and Therapeutic Market
    - 7.4.4.1.1 Brazil Exosome Diagnostic and Therapeutic Market by Application
    - 7.4.4.1.2 Brazil Exosome Diagnostic and Therapeutic Market by Product
    - 7.4.4.1.3 Brazil Exosome Diagnostic and Therapeutic Market by End User
  - 7.4.4.2 Argentina Exosome Diagnostic and Therapeutic Market
    - 7.4.4.2.1 Argentina Exosome Diagnostic and Therapeutic Market by Application
    - 7.4.4.2.2 Argentina Exosome Diagnostic and Therapeutic Market by Product
    - 7.4.4.2.3 Argentina Exosome Diagnostic and Therapeutic Market by End User
  - 7.4.4.3 UAE Exosome Diagnostic and Therapeutic Market
    - 7.4.4.3.1 UAE Exosome Diagnostic and Therapeutic Market by Application
    - 7.4.4.3.2 UAE Exosome Diagnostic and Therapeutic Market by Product
    - 7.4.4.3.3 UAE Exosome Diagnostic and Therapeutic Market by End User
  - 7.4.4.4 Saudi Arabia Exosome Diagnostic and Therapeutic Market
    - 7.4.4.4.1 Saudi Arabia Exosome Diagnostic and Therapeutic Market by Application
    - 7.4.4.4.2 Saudi Arabia Exosome Diagnostic and Therapeutic Market by Product
    - 7.4.4.4.3 Saudi Arabia Exosome Diagnostic and Therapeutic Market by End User
  - 7.4.4.5 South Africa Exosome Diagnostic and Therapeutic Market
    - 7.4.4.5.1 South Africa Exosome Diagnostic and Therapeutic Market by Application
    - 7.4.4.5.2 South Africa Exosome Diagnostic and Therapeutic Market by Product
    - 7.4.4.5.3 South Africa Exosome Diagnostic and Therapeutic Market by End User
  - 7.4.4.6 Nigeria Exosome Diagnostic and Therapeutic Market
    - 7.4.4.6.1 Nigeria Exosome Diagnostic and Therapeutic Market by Application
    - 7.4.4.6.2 Nigeria Exosome Diagnostic and Therapeutic Market by Product
    - 7.4.4.6.3 Nigeria Exosome Diagnostic and Therapeutic Market by End User
  - 7.4.4.7 Rest of LAMEA Exosome Diagnostic and Therapeutic Market
    - 7.4.4.7.1 Rest of LAMEA Exosome Diagnostic and Therapeutic Market by Application
    - 7.4.4.7.2 Rest of LAMEA Exosome Diagnostic and Therapeutic Market by Product
    - 7.4.4.7.3 Rest of LAMEA Exosome Diagnostic and Therapeutic Market by End User

Chapter 8. Company Profiles

8.1 Bio-Techne Corporation (Exosome Diagnostic, Inc.)
- 8.1.1 Company Overview
- 8.1.2 Financial Analysis
- 8.1.3 Segmental and Regional Analysis
- 8.1.4 Research & Development Expense
- 8.1.5 Recent strategies and developments:
  - 8.1.5.1 Partnerships, Collaborations, and Agreements:
8.2 Qiagen N.V.
- 8.2.1 Company Overview
- 8.2.2 Financial Analysis
- 8.2.3 Regional Analysis
- 8.2.4 Research & Development Expense
8.3 Thermo Fisher Scientific, Inc.
- 8.3.1 Company Overview
- 8.3.2 Financial Analysis
- 8.3.3 Segmental and Regional Analysis
- 8.3.4 Research & Development Expense
- 8.3.5 Recent strategies and developments:
  - 8.3.5.1 Partnerships, Collaborations, and Agreements:
8.4 Aethlon Medical, Inc.
- 8.4.1 Company Overview
- 8.4.2 Financial Analysis
- 8.4.3 Research & Development Expenses
8.5 Capricor Therapeutics, Inc.
- 8.5.1 Company Overview
- 8.5.2 Financial Analysis
- 8.5.3 Research & Development Expenses
- 8.5.4 Recent strategies and developments:
  - 8.5.4.1 Partnerships, Collaborations, and Agreements:
8.6 Malvern Panalytical Ltd. (Spectris plc)
- 8.6.1 Company Overview
- 8.6.2 Financial Analysis
- 8.6.3 Segmental and Regional Analysis
- 8.6.4 Research & Development Expenses
8.7 Nanosomix, Inc.
- 8.7.1 Company Overview
8.8 System Biosciences, LLC
- 8.8.1 Company Overview
8.9 NX Pharmagen, Inc. (NX Prenatal, Inc.)
- 8.9.1 Company Overview

LIST OF TABLES

TABLE 1 Global Exosome Diagnostic and Therapeutic Market, 2018 - 2021, USD Million
TABLE 2 Global Exosome Diagnostic and Therapeutic Market, 2022 - 2028, USD Million
TABLE 3 Global Exosome Diagnostic and Therapeutic Market by Application, 2018 - 2021, USD Million
TABLE 4 Global Exosome Diagnostic and Therapeutic Market by Application, 2022 - 2028, USD Million
TABLE 5 Global Diagnostic Market by Region, 2018 - 2021, USD Million
TABLE 6 Global Diagnostic Market by Region, 2022 - 2028, USD Million
TABLE 7 Global Therapeutic Market by Region, 2018 - 2021, USD Million
TABLE 8 Global Therapeutic Market by Region, 2022 - 2028, USD Million
TABLE 9 Global Exosome Diagnostic and Therapeutic Market by Product, 2018 - 2021, USD Million
TABLE 10 Global Exosome Diagnostic and Therapeutic Market by Product, 2022 - 2028, USD Million
TABLE 11 Global Reagent Market by Region, 2018 - 2021, USD Million
TABLE 12 Global Reagent Market by Region, 2022 - 2028, USD Million
TABLE 13 Global Instrument Market by Region, 2018 - 2021, USD Million
TABLE 14 Global Instrument Market by Region, 2022 - 2028, USD Million
TABLE 15 Global Software Market by Region, 2018 - 2021, USD Million
TABLE 16 Global Software Market by Region, 2022 - 2028, USD Million
TABLE 17 Global Exosome Diagnostic and Therapeutic Market by End User, 2018 - 2021, USD Million
TABLE 18 Global Exosome Diagnostic and Therapeutic Market by End User, 2022 - 2028, USD Million
TABLE 19 Global Cancer Institute Market by Region, 2018 - 2021, USD Million
TABLE 20 Global Cancer Institute Market by Region, 2022 - 2028, USD Million
TABLE 21 Global Hospital Market by Region, 2018 - 2021, USD Million
TABLE 22 Global Hospital Market by Region, 2022 - 2028, USD Million
TABLE 23 Global Diagnostic Center Market by Region, 2018 - 2021, USD Million
TABLE 24 Global Diagnostic Center Market by Region, 2022 - 2028, USD Million
TABLE 25 Global Others Market by Region, 2018 - 2021, USD Million
TABLE 26 Global Others Market by Region, 2022 - 2028, USD Million
TABLE 27 Global Exosome Diagnostic and Therapeutic Market by Region, 2018 - 2021, USD Million
TABLE 28 Global Exosome Diagnostic and Therapeutic Market by Region, 2022 - 2028, USD Million
TABLE 29 North America Exosome Diagnostic and Therapeutic Market, 2018 - 2021, USD Million
TABLE 30 North America Exosome Diagnostic and Therapeutic Market, 2022 - 2028, USD Million
TABLE 31 North America Exosome Diagnostic and Therapeutic Market by Application, 2018 - 2021, USD Million
TABLE 32 North America Exosome Diagnostic and Therapeutic Market by Application, 2022 - 2028, USD Million
TABLE 33 North America Diagnostic Market by Country, 2018 - 2021, USD Million
TABLE 34 North America Diagnostic Market by Country, 2022 - 2028, USD Million
TABLE 35 North America Therapeutic Market by Country, 2018 - 2021, USD Million
TABLE 36 North America Therapeutic Market by Country, 2022 - 2028, USD Million
TABLE 37 North America Exosome Diagnostic and Therapeutic Market by Product, 2018 - 2021, USD Million
TABLE 38 North America Exosome Diagnostic and Therapeutic Market by Product, 2022 - 2028, USD Million
TABLE 39 North America Reagent Market by Country, 2018 - 2021, USD Million
TABLE 40 North America Reagent Market by Country, 2022 - 2028, USD Million
TABLE 41 North America Instrument Market by Country, 2018 - 2021, USD Million
TABLE 42 North America Instrument Market by Country, 2022 - 2028, USD Million
TABLE 43 North America Software Market by Country, 2018 - 2021, USD Million
TABLE 44 North America Software Market by Country, 2022 - 2028, USD Million
TABLE 45 North America Exosome Diagnostic and Therapeutic Market by End User, 2018 - 2021, USD Million
TABLE 46 North America Exosome Diagnostic and Therapeutic Market by End User, 2022 - 2028, USD Million
TABLE 47 North America Cancer Institute Market by Country, 2018 - 2021, USD Million
TABLE 48 North America Cancer Institute Market by Country, 2022 - 2028, USD Million
TABLE 49 North America Hospital Market by Country, 2018 - 2021, USD Million
TABLE 50 North America Hospital Market by Country, 2022 - 2028, USD Million
TABLE 51 North America Diagnostic Center Market by Country, 2018 - 2021, USD Million
TABLE 52 North America Diagnostic Center Market by Country, 2022 - 2028, USD Million
TABLE 53 North America Others Market by Country, 2018 - 2021, USD Million
TABLE 54 North America Others Market by Country, 2022 - 2028, USD Million
TABLE 55 North America Exosome Diagnostic and Therapeutic Market by Country, 2018 - 2021, USD Million
TABLE 56 North America Exosome Diagnostic and Therapeutic Market by Country, 2022 - 2028, USD Million
TABLE 57 US Exosome Diagnostic and Therapeutic Market, 2018 - 2021, USD Million
TABLE 58 US Exosome Diagnostic and Therapeutic Market, 2022 - 2028, USD Million
TABLE 59 US Exosome Diagnostic and Therapeutic Market by Application, 2018 - 2021, USD Million
TABLE 60 US Exosome Diagnostic and Therapeutic Market by Application, 2022 - 2028, USD Million
TABLE 61 US Exosome Diagnostic and Therapeutic Market by Product, 2018 - 2021, USD Million
TABLE 62 US Exosome Diagnostic and Therapeutic Market by Product, 2022 - 2028, USD Million
TABLE 63 US Exosome Diagnostic and Therapeutic Market by End User, 2018 - 2021, USD Million
TABLE 64 US Exosome Diagnostic and Therapeutic Market by End User, 2022 - 2028, USD Million
TABLE 65 Canada Exosome Diagnostic and Therapeutic Market, 2018 - 2021, USD Million
TABLE 66 Canada Exosome Diagnostic and Therapeutic Market, 2022 - 2028, USD Million
TABLE 67 Canada Exosome Diagnostic and Therapeutic Market by Application, 2018 - 2021, USD Million
TABLE 68 Canada Exosome Diagnostic and Therapeutic Market by Application, 2022 - 2028, USD Million
TABLE 69 Canada Exosome Diagnostic and Therapeutic Market by Product, 2018 - 2021, USD Million
TABLE 70 Canada Exosome Diagnostic and Therapeutic Market by Product, 2022 - 2028, USD Million
TABLE 71 Canada Exosome Diagnostic and Therapeutic Market by End User, 2018 - 2021, USD Million
TABLE 72 Canada Exosome Diagnostic and Therapeutic Market by End User, 2022 - 2028, USD Million
TABLE 73 Mexico Exosome Diagnostic and Therapeutic Market, 2018 - 2021, USD Million
TABLE 74 Mexico Exosome Diagnostic and Therapeutic Market, 2022 - 2028, USD Million
TABLE 75 Mexico Exosome Diagnostic and Therapeutic Market by Application, 2018 - 2021, USD Million
TABLE 76 Mexico Exosome Diagnostic and Therapeutic Market by Application, 2022 - 2028, USD Million
TABLE 77 Mexico Exosome Diagnostic and Therapeutic Market by Product, 2018 - 2021, USD Million
TABLE 78 Mexico Exosome Diagnostic and Therapeutic Market by Product, 2022 - 2028, USD Million
TABLE 79 Mexico Exosome Diagnostic and Therapeutic Market by End User, 2018 - 2021, USD Million
TABLE 80 Mexico Exosome Diagnostic and Therapeutic Market by End User, 2022 - 2028, USD Million
TABLE 81 Rest of North America Exosome Diagnostic and Therapeutic Market, 2018 - 2021, USD Million
TABLE 82 Rest of North America Exosome Diagnostic and Therapeutic Market, 2022 - 2028, USD Million
TABLE 83 Rest of North America Exosome Diagnostic and Therapeutic Market by Application, 2018 - 2021, USD Million
TABLE 84 Rest of North America Exosome Diagnostic and Therapeutic Market by Application, 2022 - 2028, USD Million
TABLE 85 Rest of North America Exosome Diagnostic and Therapeutic Market by Product, 2018 - 2021, USD Million
TABLE 86 Rest of North America Exosome Diagnostic and Therapeutic Market by Product, 2022 - 2028, USD Million
TABLE 87 Rest of North America Exosome Diagnostic and Therapeutic Market by End User, 2018 - 2021, USD Million
TABLE 88 Rest of North America Exosome Diagnostic and Therapeutic Market by End User, 2022 - 2028, USD Million
TABLE 89 Europe Exosome Diagnostic and Therapeutic Market, 2018 - 2021, USD Million
TABLE 90 Europe Exosome Diagnostic and Therapeutic Market, 2022 - 2028, USD Million
TABLE 91 Europe Exosome Diagnostic and Therapeutic Market by Application, 2018 - 2021, USD Million
TABLE 92 Europe Exosome Diagnostic and Therapeutic Market by Application, 2022 - 2028, USD Million
TABLE 93 Europe Diagnostic Market by Country, 2018 - 2021, USD Million
TABLE 94 Europe Diagnostic Market by Country, 2022 - 2028, USD Million
TABLE 95 Europe Therapeutic Market by Country, 2018 - 2021, USD Million
TABLE 96 Europe Therapeutic Market by Country, 2022 - 2028, USD Million
TABLE 97 Europe Exosome Diagnostic and Therapeutic Market by Product, 2018 - 2021, USD Million
TABLE 98 Europe Exosome Diagnostic and Therapeutic Market by Product, 2022 - 2028, USD Million
TABLE 99 Europe Reagent Market by Country, 2018 - 2021, USD Million
TABLE 100 Europe Reagent Market by Country, 2022 - 2028, USD Million
TABLE 101 Europe Instrument Market by Country, 2018 - 2021, USD Million
TABLE 102 Europe Instrument Market by Country, 2022 - 2028, USD Million
TABLE 103 Europe Software Market by Country, 2018 - 2021, USD Million
TABLE 104 Europe Software Market by Country, 2022 - 2028, USD Million
TABLE 105 Europe Exosome Diagnostic and Therapeutic Market by End User, 2018 - 2021, USD Million
TABLE 106 Europe Exosome Diagnostic and Therapeutic Market by End User, 2022 - 2028, USD Million
TABLE 107 Europe Cancer Institute Market by Country, 2018 - 2021, USD Million
TABLE 108 Europe Cancer Institute Market by Country, 2022 - 2028, USD Million
TABLE 109 Europe Hospital Market by Country, 2018 - 2021, USD Million
TABLE 110 Europe Hospital Market by Country, 2022 - 2028, USD Million
TABLE 111 Europe Diagnostic Center Market by Country, 2018 - 2021, USD Million
TABLE 112 Europe Diagnostic Center Market by Country, 2022 - 2028, USD Million
TABLE 113 Europe Others Market by Country, 2018 - 2021, USD Million
TABLE 114 Europe Others Market by Country, 2022 - 2028, USD Million
TABLE 115 Europe Exosome Diagnostic and Therapeutic Market by Country, 2018 - 2021, USD Million
TABLE 116 Europe Exosome Diagnostic and Therapeutic Market by Country, 2022 - 2028, USD Million
TABLE 117 Germany Exosome Diagnostic and Therapeutic Market, 2018 - 2021, USD Million
TABLE 118 Germany Exosome Diagnostic and Therapeutic Market, 2022 - 2028, USD Million
TABLE 119 Germany Exosome Diagnostic and Therapeutic Market by Application, 2018 - 2021, USD Million
TABLE 120 Germany Exosome Diagnostic and Therapeutic Market by Application, 2022 - 2028, USD Million
TABLE 121 Germany Exosome Diagnostic and Therapeutic Market by Product, 2018 - 2021, USD Million
TABLE 122 Germany Exosome Diagnostic and Therapeutic Market by Product, 2022 - 2028, USD Million
TABLE 123 Germany Exosome Diagnostic and Therapeutic Market by End User, 2018 - 2021, USD Million
TABLE 124 Germany Exosome Diagnostic and Therapeutic Market by End User, 2022 - 2028, USD Million
TABLE 125 UK Exosome Diagnostic and Therapeutic Market, 2018 - 2021, USD Million
TABLE 126 UK Exosome Diagnostic and Therapeutic Market, 2022 - 2028, USD Million
TABLE 127 UK Exosome Diagnostic and Therapeutic Market by Application, 2018 - 2021, USD Million
TABLE 128 UK Exosome Diagnostic and Therapeutic Market by Application, 2022 - 2028, USD Million
TABLE 129 UK Exosome Diagnostic and Therapeutic Market by Product, 2018 - 2021, USD Million
TABLE 130 UK Exosome Diagnostic and Therapeutic Market by Product, 2022 - 2028, USD Million
TABLE 131 UK Exosome Diagnostic and Therapeutic Market by End User, 2018 - 2021, USD Million
TABLE 132 UK Exosome Diagnostic and Therapeutic Market by End User, 2022 - 2028, USD Million
TABLE 133 France Exosome Diagnostic and Therapeutic Market, 2018 - 2021, USD Million
TABLE 134 France Exosome Diagnostic and Therapeutic Market, 2022 - 2028, USD Million
TABLE 135 France Exosome Diagnostic and Therapeutic Market by Application, 2018 - 2021, USD Million
TABLE 136 France Exosome Diagnostic and Therapeutic Market by Application, 2022 - 2028, USD Million
TABLE 137 France Exosome Diagnostic and Therapeutic Market by Product, 2018 - 2021, USD Million
TABLE 138 France Exosome Diagnostic and Therapeutic Market by Product, 2022 - 2028, USD Million
TABLE 139 France Exosome Diagnostic and Therapeutic Market by End User, 2018 - 2021, USD Million
TABLE 140 France Exosome Diagnostic and Therapeutic Market by End User, 2022 - 2028, USD Million
TABLE 141 Russia Exosome Diagnostic and Therapeutic Market, 2018 - 2021, USD Million
TABLE 142 Russia Exosome Diagnostic and Therapeutic Market, 2022 - 2028, USD Million
TABLE 143 Russia Exosome Diagnostic and Therapeutic Market by Application, 2018 - 2021, USD Million
TABLE 144 Russia Exosome Diagnostic and Therapeutic Market by Application, 2022 - 2028, USD Million
TABLE 145 Russia Exosome Diagnostic and Therapeutic Market by Product, 2018 - 2021, USD Million
TABLE 146 Russia Exosome Diagnostic and Therapeutic Market by Product, 2022 - 2028, USD Million
TABLE 147 Russia Exosome Diagnostic and Therapeutic Market by End User, 2018 - 2021, USD Million
TABLE 148 Russia Exosome Diagnostic and Therapeutic Market by End User, 2022 - 2028, USD Million
TABLE 149 Spain Exosome Diagnostic and Therapeutic Market, 2018 - 2021, USD Million
TABLE 150 Spain Exosome Diagnostic and Therapeutic Market, 2022 - 2028, USD Million
TABLE 151 Spain Exosome Diagnostic and Therapeutic Market by Application, 2018 - 2021, USD Million
TABLE 152 Spain Exosome Diagnostic and Therapeutic Market by Application, 2022 - 2028, USD Million
TABLE 153 Spain Exosome Diagnostic and Therapeutic Market by Product, 2018 - 2021, USD Million
TABLE 154 Spain Exosome Diagnostic and Therapeutic Market by Product, 2022 - 2028, USD Million
TABLE 155 Spain Exosome Diagnostic and Therapeutic Market by End User, 2018 - 2021, USD Million
TABLE 156 Spain Exosome Diagnostic and Therapeutic Market by End User, 2022 - 2028, USD Million
TABLE 157 Italy Exosome Diagnostic and Therapeutic Market, 2018 - 2021, USD Million
TABLE 158 Italy Exosome Diagnostic and Therapeutic Market, 2022 - 2028, USD Million
TABLE 159 Italy Exosome Diagnostic and Therapeutic Market by Application, 2018 - 2021, USD Million
TABLE 160 Italy Exosome Diagnostic and Therapeutic Market by Application, 2022 - 2028, USD Million
TABLE 161 Italy Exosome Diagnostic and Therapeutic Market by Product, 2018 - 2021, USD Million
TABLE 162 Italy Exosome Diagnostic and Therapeutic Market by Product, 2022 - 2028, USD Million
TABLE 163 Italy Exosome Diagnostic and Therapeutic Market by End User, 2018 - 2021, USD Million
TABLE 164 Italy Exosome Diagnostic and Therapeutic Market by End User, 2022 - 2028, USD Million
TABLE 165 Rest of Europe Exosome Diagnostic and Therapeutic Market, 2018 - 2021, USD Million
TABLE 166 Rest of Europe Exosome Diagnostic and Therapeutic Market, 2022 - 2028, USD Million
TABLE 167 Rest of Europe Exosome Diagnostic and Therapeutic Market by Application, 2018 - 2021, USD Million
TABLE 168 Rest of Europe Exosome Diagnostic and Therapeutic Market by Application, 2022 - 2028, USD Million
TABLE 169 Rest of Europe Exosome Diagnostic and Therapeutic Market by Product, 2018 - 2021, USD Million
TABLE 170 Rest of Europe Exosome Diagnostic and Therapeutic Market by Product, 2022 - 2028, USD Million
TABLE 171 Rest of Europe Exosome Diagnostic and Therapeutic Market by End User, 2018 - 2021, USD Million
TABLE 172 Rest of Europe Exosome Diagnostic and Therapeutic Market by End User, 2022 - 2028, USD Million
TABLE 173 Asia Pacific Exosome Diagnostic and Therapeutic Market, 2018 - 2021, USD Million
TABLE 174 Asia Pacific Exosome Diagnostic and Therapeutic Market, 2022 - 2028, USD Million
TABLE 175 Asia Pacific Exosome Diagnostic and Therapeutic Market by Application, 2018 - 2021, USD Million
TABLE 176 Asia Pacific Exosome Diagnostic and Therapeutic Market by Application, 2022 - 2028, USD Million
TABLE 177 Asia Pacific Diagnostic Market by Country, 2018 - 2021, USD Million
TABLE 178 Asia Pacific Diagnostic Market by Country, 2022 - 2028, USD Million
TABLE 179 Asia Pacific Therapeutic Market by Country, 2018 - 2021, USD Million
TABLE 180 Asia Pacific Therapeutic Market by Country, 2022 - 2028, USD Million
TABLE 181 Asia Pacific Exosome Diagnostic and Therapeutic Market by Product, 2018 - 2021, USD Million
TABLE 182 Asia Pacific Exosome Diagnostic and Therapeutic Market by Product, 2022 - 2028, USD Million
TABLE 183 Asia Pacific Reagent Market by Country, 2018 - 2021, USD Million
TABLE 184 Asia Pacific Reagent Market by Country, 2022 - 2028, USD Million
TABLE 185 Asia Pacific Instrument Market by Country, 2018 - 2021, USD Million
TABLE 186 Asia Pacific Instrument Market by Country, 2022 - 2028, USD Million
TABLE 187 Asia Pacific Software Market by Country, 2018 - 2021, USD Million
TABLE 188 Asia Pacific Software Market by Country, 2022 - 2028, USD Million
TABLE 189 Asia Pacific Exosome Diagnostic and Therapeutic Market by End User, 2018 - 2021, USD Million
TABLE 190 Asia Pacific Exosome Diagnostic and Therapeutic Market by End User, 2022 - 2028, USD Million
TABLE 191 Asia Pacific Cancer Institute Market by Country, 2018 - 2021, USD Million
TABLE 192 Asia Pacific Cancer Institute Market by Country, 2022 - 2028, USD Million
TABLE 193 Asia Pacific Hospital Market by Country, 2018 - 2021, USD Million
TABLE 194 Asia Pacific Hospital Market by Country, 2022 - 2028, USD Million
TABLE 195 Asia Pacific Diagnostic Center Market by Country, 2018 - 2021, USD Million
TABLE 196 Asia Pacific Diagnostic Center Market by Country, 2022 - 2028, USD Million
TABLE 197 Asia Pacific Others Market by Country, 2018 - 2021, USD Million
TABLE 198 Asia Pacific Others Market by Country, 2022 - 2028, USD Million
TABLE 199 Asia Pacific Exosome Diagnostic and Therapeutic Market by Country, 2018 - 2021, USD Million
TABLE 200 Asia Pacific Exosome Diagnostic and Therapeutic Market by Country, 2022 - 2028, USD Million
TABLE 201 China Exosome Diagnostic and Therapeutic Market, 2018 - 2021, USD Million
TABLE 202 China Exosome Diagnostic and Therapeutic Market, 2022 - 2028, USD Million
TABLE 203 China Exosome Diagnostic and Therapeutic Market by Application, 2018 - 2021, USD Million
TABLE 204 China Exosome Diagnostic and Therapeutic Market by Application, 2022 - 2028, USD Million
TABLE 205 China Exosome Diagnostic and Therapeutic Market by Product, 2018 - 2021, USD Million
TABLE 206 China Exosome Diagnostic and Therapeutic Market by Product, 2022 - 2028, USD Million
TABLE 207 China Exosome Diagnostic and Therapeutic Market by End User, 2018 - 2021, USD Million
TABLE 208 China Exosome Diagnostic and Therapeutic Market by End User, 2022 - 2028, USD Million
TABLE 209 Japan Exosome Diagnostic and Therapeutic Market, 2018 - 2021, USD Million
TABLE 210 Japan Exosome Diagnostic and Therapeutic Market, 2022 - 2028, USD Million
TABLE 211 Japan Exosome Diagnostic and Therapeutic Market by Application, 2018 - 2021, USD Million
TABLE 212 Japan Exosome Diagnostic and Therapeutic Market by Application, 2022 - 2028, USD Million
TABLE 213 Japan Exosome Diagnostic and Therapeutic Market by Product, 2018 - 2021, USD Million
TABLE 214 Japan Exosome Diagnostic and Therapeutic Market by Product, 2022 - 2028, USD Million
TABLE 215 Japan Exosome Diagnostic and Therapeutic Market by End User, 2018 - 2021, USD Million
TABLE 216 Japan Exosome Diagnostic and Therapeutic Market by End User, 2022 - 2028, USD Million
TABLE 217 India Exosome Diagnostic and Therapeutic Market, 2018 - 2021, USD Million
TABLE 218 India Exosome Diagnostic and Therapeutic Market, 2022 - 2028, USD Million
TABLE 219 India Exosome Diagnostic and Therapeutic Market by Application, 2018 - 2021, USD Million
TABLE 220 India Exosome Diagnostic and Therapeutic Market by Application, 2022 - 2028, USD Million
TABLE 221 India Exosome Diagnostic and Therapeutic Market by Product, 2018 - 2021, USD Million
TABLE 222 India Exosome Diagnostic and Therapeutic Market by Product, 2022 - 2028, USD Million
TABLE 223 India Exosome Diagnostic and Therapeutic Market by End User, 2018 - 2021, USD Million
TABLE 224 India Exosome Diagnostic and Therapeutic Market by End User, 2022 - 2028, USD Million
TABLE 225 South Korea Exosome Diagnostic and Therapeutic Market, 2018 - 2021, USD Million
TABLE 226 South Korea Exosome Diagnostic and Therapeutic Market, 2022 - 2028, USD Million
TABLE 227 South Korea Exosome Diagnostic and Therapeutic Market by Application, 2018 - 2021, USD Million
TABLE 228 South Korea Exosome Diagnostic and Therapeutic Market by Application, 2022 - 2028, USD Million
TABLE 229 South Korea Exosome Diagnostic and Therapeutic Market by Product, 2018 - 2021, USD Million
TABLE 230 South Korea Exosome Diagnostic and Therapeutic Market by Product, 2022 - 2028, USD Million
TABLE 231 South Korea Exosome Diagnostic and Therapeutic Market by End User, 2018 - 2021, USD Million
TABLE 232 South Korea Exosome Diagnostic and Therapeutic Market by End User, 2022 - 2028, USD Million
TABLE 233 Singapore Exosome Diagnostic and Therapeutic Market, 2018 - 2021, USD Million
TABLE 234 Singapore Exosome Diagnostic and Therapeutic Market, 2022 - 2028, USD Million
TABLE 235 Singapore Exosome Diagnostic and Therapeutic Market by Application, 2018 - 2021, USD Million
TABLE 236 Singapore Exosome Diagnostic and Therapeutic Market by Application, 2022 - 2028, USD Million
TABLE 237 Singapore Exosome Diagnostic and Therapeutic Market by Product, 2018 - 2021, USD Million
TABLE 238 Singapore Exosome Diagnostic and Therapeutic Market by Product, 2022 - 2028, USD Million
TABLE 239 Singapore Exosome Diagnostic and Therapeutic Market by End User, 2018 - 2021, USD Million
TABLE 240 Singapore Exosome Diagnostic and Therapeutic Market by End User, 2022 - 2028, USD Million
TABLE 241 Malaysia Exosome Diagnostic and Therapeutic Market, 2018 - 2021, USD Million
TABLE 242 Malaysia Exosome Diagnostic and Therapeutic Market, 2022 - 2028, USD Million
TABLE 243 Malaysia Exosome Diagnostic and Therapeutic Market by Application, 2018 - 2021, USD Million
TABLE 244 Malaysia Exosome Diagnostic and Therapeutic Market by Application, 2022 - 2028, USD Million
TABLE 245 Malaysia Exosome Diagnostic and Therapeutic Market by Product, 2018 - 2021, USD Million
TABLE 246 Malaysia Exosome Diagnostic and Therapeutic Market by Product, 2022 - 2028, USD Million
TABLE 247 Malaysia Exosome Diagnostic and Therapeutic Market by End User, 2018 - 2021, USD Million
TABLE 248 Malaysia Exosome Diagnostic and Therapeutic Market by End User, 2022 - 2028, USD Million
TABLE 249 Rest of Asia Pacific Exosome Diagnostic and Therapeutic Market, 2018 - 2021, USD Million
TABLE 250 Rest of Asia Pacific Exosome Diagnostic and Therapeutic Market, 2022 - 2028, USD Million
TABLE 251 Rest of Asia Pacific Exosome Diagnostic and Therapeutic Market by Application, 2018 - 2021, USD Million
TABLE 252 Rest of Asia Pacific Exosome Diagnostic and Therapeutic Market by Application, 2022 - 2028, USD Million
TABLE 253 Rest of Asia Pacific Exosome Diagnostic and Therapeutic Market by Product, 2018 - 2021, USD Million
TABLE 254 Rest of Asia Pacific Exosome Diagnostic and Therapeutic Market by Product, 2022 - 2028, USD Million
TABLE 255 Rest of Asia Pacific Exosome Diagnostic and Therapeutic Market by End User, 2018 - 2021, USD Million
TABLE 256 Rest of Asia Pacific Exosome Diagnostic and Therapeutic Market by End User, 2022 - 2028, USD Million
TABLE 257 LAMEA Exosome Diagnostic and Therapeutic Market, 2018 - 2021, USD Million
TABLE 258 LAMEA Exosome Diagnostic and Therapeutic Market, 2022 - 2028, USD Million
TABLE 259 LAMEA Exosome Diagnostic and Therapeutic Market by Application, 2018 - 2021, USD Million
TABLE 260 LAMEA Exosome Diagnostic and Therapeutic Market by Application, 2022 - 2028, USD Million
TABLE 261 LAMEA Diagnostic Market by Country, 2018 - 2021, USD Million
TABLE 262 LAMEA Diagnostic Market by Country, 2022 - 2028, USD Million
TABLE 263 LAMEA Therapeutic Market by Country, 2018 - 2021, USD Million
TABLE 264 LAMEA Therapeutic Market by Country, 2022 - 2028, USD Million
TABLE 265 LAMEA Exosome Diagnostic and Therapeutic Market by Product, 2018 - 2021, USD Million
TABLE 266 LAMEA Exosome Diagnostic and Therapeutic Market by Product, 2022 - 2028, USD Million
TABLE 267 LAMEA Reagent Market by Country, 2018 - 2021, USD Million
TABLE 268 LAMEA Reagent Market by Country, 2022 - 2028, USD Million
TABLE 269 LAMEA Instrument Market by Country, 2018 - 2021, USD Million
TABLE 270 LAMEA Instrument Market by Country, 2022 - 2028, USD Million
TABLE 271 LAMEA Software Market by Country, 2018 - 2021, USD Million
TABLE 272 LAMEA Software Market by Country, 2022 - 2028, USD Million
TABLE 273 LAMEA Exosome Diagnostic and Therapeutic Market by End User, 2018 - 2021, USD Million
TABLE 274 LAMEA Exosome Diagnostic and Therapeutic Market by End User, 2022 - 2028, USD Million
TABLE 275 LAMEA Cancer Institute Market by Country, 2018 - 2021, USD Million
TABLE 276 LAMEA Cancer Institute Market by Country, 2022 - 2028, USD Million
TABLE 277 LAMEA Hospital Market by Country, 2018 - 2021, USD Million
TABLE 278 LAMEA Hospital Market by Country, 2022 - 2028, USD Million
TABLE 279 LAMEA Diagnostic Center Market by Country, 2018 - 2021, USD Million
TABLE 280 LAMEA Diagnostic Center Market by Country, 2022 - 2028, USD Million
TABLE 281 LAMEA Others Market by Country, 2018 - 2021, USD Million
TABLE 282 LAMEA Others Market by Country, 2022 - 2028, USD Million
TABLE 283 LAMEA Exosome Diagnostic and Therapeutic Market by Country, 2018 - 2021, USD Million
TABLE 284 LAMEA Exosome Diagnostic and Therapeutic Market by Country, 2022 - 2028, USD Million
TABLE 285 Brazil Exosome Diagnostic and Therapeutic Market, 2018 - 2021, USD Million
TABLE 286 Brazil Exosome Diagnostic and Therapeutic Market, 2022 - 2028, USD Million
TABLE 287 Brazil Exosome Diagnostic and Therapeutic Market by Application, 2018 - 2021, USD Million
TABLE 288 Brazil Exosome Diagnostic and Therapeutic Market by Application, 2022 - 2028, USD Million
TABLE 289 Brazil Exosome Diagnostic and Therapeutic Market by Product, 2018 - 2021, USD Million
TABLE 290 Brazil Exosome Diagnostic and Therapeutic Market by Product, 2022 - 2028, USD Million
TABLE 291 Brazil Exosome Diagnostic and Therapeutic Market by End User, 2018 - 2021, USD Million
TABLE 292 Brazil Exosome Diagnostic and Therapeutic Market by End User, 2022 - 2028, USD Million
TABLE 293 Argentina Exosome Diagnostic and Therapeutic Market, 2018 - 2021, USD Million
TABLE 294 Argentina Exosome Diagnostic and Therapeutic Market, 2022 - 2028, USD Million
TABLE 295 Argentina Exosome Diagnostic and Therapeutic Market by Application, 2018 - 2021, USD Million
TABLE 296 Argentina Exosome Diagnostic and Therapeutic Market by Application, 2022 - 2028, USD Million
TABLE 297 Argentina Exosome Diagnostic and Therapeutic Market by Product, 2018 - 2021, USD Million
TABLE 298 Argentina Exosome Diagnostic and Therapeutic Market by Product, 2022 - 2028, USD Million
TABLE 299 Argentina Exosome Diagnostic and Therapeutic Market by End User, 2018 - 2021, USD Million
TABLE 300 Argentina Exosome Diagnostic and Therapeutic Market by End User, 2022 - 2028, USD Million
TABLE 301 UAE Exosome Diagnostic and Therapeutic Market, 2018 - 2021, USD Million
TABLE 302 UAE Exosome Diagnostic and Therapeutic Market, 2022 - 2028, USD Million
TABLE 303 UAE Exosome Diagnostic and Therapeutic Market by Application, 2018 - 2021, USD Million
TABLE 304 UAE Exosome Diagnostic and Therapeutic Market by Application, 2022 - 2028, USD Million
TABLE 305 UAE Exosome Diagnostic and Therapeutic Market by Product, 2018 - 2021, USD Million
TABLE 306 UAE Exosome Diagnostic and Therapeutic Market by Product, 2022 - 2028, USD Million
TABLE 307 UAE Exosome Diagnostic and Therapeutic Market by End User, 2018 - 2021, USD Million
TABLE 308 UAE Exosome Diagnostic and Therapeutic Market by End User, 2022 - 2028, USD Million

TABLE 309 Saudi Arabia Exosome Diagnostic and Therapeutic Market, 2018 - 2021, USD Million
TABLE 310 Saudi Arabia Exosome Diagnostic and Therapeutic Market, 2022 - 2028, USD Million
TABLE 311 Saudi Arabia Exosome Diagnostic and Therapeutic Market by Application, 2018 - 2021, USD Million
TABLE 312 Saudi Arabia Exosome Diagnostic and Therapeutic Market by Application, 2022 - 2028, USD Million
TABLE 313 Saudi Arabia Exosome Diagnostic and Therapeutic Market by Product, 2018 - 2021, USD Million
TABLE 314 Saudi Arabia Exosome Diagnostic and Therapeutic Market by Product, 2022 - 2028, USD Million
TABLE 315 Saudi Arabia Exosome Diagnostic and Therapeutic Market by End User, 2018 - 2021, USD Million
TABLE 316 Saudi Arabia Exosome Diagnostic and Therapeutic Market by End User, 2022 - 2028, USD Million
TABLE 317 South Africa Exosome Diagnostic and Therapeutic Market, 2018 - 2021, USD Million
TABLE 318 South Africa Exosome Diagnostic and Therapeutic Market, 2022 - 2028, USD Million
TABLE 319 South Africa Exosome Diagnostic and Therapeutic Market by Application, 2018 - 2021, USD Million
TABLE 320 South Africa Exosome Diagnostic and Therapeutic Market by Application, 2022 - 2028, USD Million
TABLE 321 South Africa Exosome Diagnostic and Therapeutic Market by Product, 2018 - 2021, USD Million
TABLE 322 South Africa Exosome Diagnostic and Therapeutic Market by Product, 2022 - 2028, USD Million
TABLE 323 South Africa Exosome Diagnostic and Therapeutic Market by End User, 2018 - 2021, USD Million
TABLE 324 South Africa Exosome Diagnostic and Therapeutic Market by End User, 2022 - 2028, USD Million
TABLE 325 Nigeria Exosome Diagnostic and Therapeutic Market, 2018 - 2021, USD Million
TABLE 326 Nigeria Exosome Diagnostic and Therapeutic Market, 2022 - 2028, USD Million
TABLE 327 Nigeria Exosome Diagnostic and Therapeutic Market by Application, 2018 - 2021, USD Million
TABLE 328 Nigeria Exosome Diagnostic and Therapeutic Market by Application, 2022 - 2028, USD Million
TABLE 329 Nigeria Exosome Diagnostic and Therapeutic Market by Product, 2018 - 2021, USD Million
TABLE 330 Nigeria Exosome Diagnostic and Therapeutic Market by Product, 2022 - 2028, USD Million
TABLE 331 Nigeria Exosome Diagnostic and Therapeutic Market by End User, 2018 - 2021, USD Million
TABLE 332 Nigeria Exosome Diagnostic and Therapeutic Market by End User, 2022 - 2028, USD Million
TABLE 333 Rest of LAMEA Exosome Diagnostic and Therapeutic Market, 2018 - 2021, USD Million
TABLE 334 Rest of LAMEA Exosome Diagnostic and Therapeutic Market, 2022 - 2028, USD Million
TABLE 335 Rest of LAMEA Exosome Diagnostic and Therapeutic Market by Application, 2018 - 2021, USD Million
TABLE 336 Rest of LAMEA Exosome Diagnostic and Therapeutic Market by Application, 2022 - 2028, USD Million
TABLE 337 Rest of LAMEA Exosome Diagnostic and Therapeutic Market by Product, 2018 - 2021, USD Million
TABLE 338 Rest of LAMEA Exosome Diagnostic and Therapeutic Market by Product, 2022 - 2028, USD Million
TABLE 339 Rest of LAMEA Exosome Diagnostic and Therapeutic Market by End User, 2018 - 2021, USD Million
TABLE 340 Rest of LAMEA Exosome Diagnostic and Therapeutic Market by End User, 2022 - 2028, USD Million
TABLE 341 key information - Bio-Techne Corporation
TABLE 342 Key Information - Qiagen N.V.
TABLE 343 Key Information - Thermo Fisher Scientific, Inc.
TABLE 344 Key Information - Aethlon Medical, Inc.
TABLE 345 Key Information - Capricor Therapeutics, Inc.
TABLE 346 Key Information - Malvern Panalytical Ltd
TABLE 347 Key Information - Nanosomix, Inc.
TABLE 348 Key Information - System Biosciences, LLC
TABLE 349 Key Information - NX Pharmagen, Inc.

List of Figures

FIG 1 Methodology for the research
FIG 2 Global Exosome Diagnostic and Therapeutic Market Share by Application, 2021
FIG 3 Global Exosome Diagnostic and Therapeutic Market Share by Application, 2028
FIG 4 Global Exosome Diagnostic and Therapeutic Market by Application, 2018 - 2028, USD Million
FIG 5 Global Exosome Diagnostic and Therapeutic Market Share by Product, 2021
FIG 6 Global Exosome Diagnostic and Therapeutic Market Share by Product, 2028
FIG 7 Global Exosome Diagnostic and Therapeutic Market by Product, 2018 - 2028, USD Million
FIG 8 Global Exosome Diagnostic and Therapeutic Market Share by End User, 2021
FIG 9 Global Exosome Diagnostic and Therapeutic Market Share by End User, 2028
FIG 10 Global Exosome Diagnostic and Therapeutic Market by End User, 2018 - 2028, USD Million
FIG 11 Global Exosome Diagnostic and Therapeutic Market Share by Region, 2021
FIG 12 Global Exosome Diagnostic and Therapeutic Market Share by Region, 2028
FIG 13 Global Exosome Diagnostic and Therapeutic Market by Region, 2018 - 2028, USD Million

Global Exosome Diagnostic and Therapeutic Market Size, Share & Industry Trends Analysis Report By Application (Diagnostic and Therapeutic), By Product (Reagent, Instrument, and Software), By End User, By Regional Outlook and Forecast, 2022 - 2028

Description

Table of Contents